NDUFB6 and neurodegenerative disease: We simulated impaired ETC activity as reported in several neurodegenerative diseases [13,15,16] by reducing the activities of complex I (CI), complex III (CIII), complex IV (CIV), or the F1Fo ATP synthase (F1), and by increasing/decreasing proton leak (Hle).